Framingham risk-based survival of non-small-cell lung cancer

Asian Cardiovascular and Thoracic Annals

Volumn 20, Issue 1, 2012, Pages 30-35

  Poullis, Michael ^a   McShane, James ^a   Shaw, Matthew ^a   Page, Richard ^a   Shackcloth, Michael ^a   Mediratta, Neeraj ^a  

^a LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

Author keywords

Cardiovascular diseases; Lung neoplasms; Risk assessment; Risk factors; Survival

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARDIOVASCULAR RISK; FEMALE; FRAMINGHAM RISK SCORE; HUMAN; KAPLAN MEIER METHOD; LONG TERM SURVIVAL; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; RECEIVER OPERATING CHARACTERISTIC; WEDGE RESECTION;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PNEUMONECTOMY; PROGNOSIS; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 84858222173     PISSN: 02184923     EISSN: 18165370     Source Type: Journal    
DOI: 10.1177/0218492311432801     Document Type: Article

References (16)

1. Shopland DR, Eyre HJ and Pechacek TF. Smoking-attributable cancer mortality in 1991: is lung cancer now the leading cause of death among smokers in the United States? J Natl Cancer Inst 1991; 83: 1142-1148.
2. Skaug K, Eide GE and Gulsvik A. Predictors of long-term survival of lung cancer patients in a Norwegian community. Clin Respir J 2011; 5: 50-58.
3. Fontaine E, McShane J, Page R, Shackcloth M, Mediratta N, Carr M, et al. Aspirin and non-small cell lung cancer resections: effect on long-term survival. Eur J Cardiothorac Surg 2010; 38: 21-26.
4. Groth SS, Rueth NM, Hodges JS, Habermann EB, Andrade RS, D'Cunha J, et al. Conditional cancer-specific versus cardiovascular-specific survival after lobectomy for stage I non-small cell lung cancer. Ann Thorac Surg 2010; 90: 375-382.
5. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007; 2: 706-714. (Pubitemid 47357522)
6. Groome PA, Bolejack V, Crowley JJ, Kennedy C, Krasnik M, Sobin LH, et al. The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007; 2: 694-705. (Pubitemid 47357521)
7. Brown WM, Beck SR, Lange EM, Davis CC, Kay CM, Langefeld CD, et al. Age-stratified heritability estimation in the Framingham Heart Study families. BMC Genet 2003; 4(Suppl 1): S32.
8. de Ruijter W, Westendorp RG, Assendelft WJ, den Elzen WP, de Craen AJ, le Cessie S, et al. Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ 2009; 338: a3083.
9. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet 1988; 2(8607): 349-360.
10. Brensike JF, Levy RI, Kelsey SF, Passamani ER, Richardson JM, Loh IK, et al. Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study. Circulation 1984; 69: 313-324. (Pubitemid 14180337)
11. Bucher HC, Griffith LE and Guyatt GH. Systematic review on the risk and benefit of different cholesterollowering interventions. Arterioscler Thromb Vasc Biol 1999; 19: 187-195. (Pubitemid 29072729)
12. Swedberg K, Held P, Kjekshus J, Rasmussen K, Rydén L and Wedel H. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II). N Engl J Med 1992; 337: 678-684.
13. Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 2001; 357(9266): 1385-1390. (Pubitemid 32455364)
14. Fahey T, Brindle P and Ebrahim S. The polypill and cardiovascular disease. BMJ 2005; 330(7499): 1035-1036. (Pubitemid 40646547)
15. Inagaki J, Rodriguez V and Bodey GP. Proceedings: causes of death in cancer patients. Cancer 1974; 33: 568-573.
16. Sheridan S, Pignone M and Mulrow C. Framingham-based tools to calculate the global risk of coronary heart disease. J Gen Intern Med 2003; 18: 1039-1052.